Lisinopril Cost in Vermont 2026: Cash Price, Medicaid, and Savings Options

What Does Lisinopril Actually Cost in Vermont Right Now?

Generic lisinopril is one of the least expensive prescription drugs available in Vermont. The average cash-pay price at Vermont retail pharmacies in 2026 runs approximately $8 per month for a standard 30-day supply of 10 mg or 20 mg tablets. That figure sits well below the manufacturer's generic list price of around $50 per month, a gap that reflects aggressive retail competition and the maturity of the generic market for ACE inhibitors.

Prices shift based on pharmacy, quantity, and dose. A 90-day supply purchased at a big-box retailer or warehouse club pharmacy may cost less per tablet than a 30-day supply at an independent corner pharmacy. Costco and Walmart pharmacies in Vermont have historically listed 90-count supplies of lisinopril 10 mg for under $12, though exact pricing changes without notice.

Discount cards narrow the spread further. GoodRx, RxSaver, and NeedyMeds all operate in Vermont and routinely return prices between $4 and $9 for a 30-day lisinopril supply at major chains including CVS, Rite Aid, Hannaford Pharmacy, and Kinney Drugs. Pharmacy benefit data from GoodRx and published cost-effectiveness research consistently show generic ACE inhibitors as among the most affordable antihypertensive options available [1].

The clinical evidence supporting lisinopril's use is substantial. ALLHAT (the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, N=33,357) compared lisinopril against chlorthalidone and amlodipine and found no significant difference in the primary combined endpoint of fatal coronary heart disease or nonfatal myocardial infarction [2]. That trial's findings anchor lisinopril firmly in first-line hypertension therapy, meaning millions of patients take it long-term and price stability matters enormously.

Vermont Medicaid Coverage for Lisinopril

Vermont Medicaid (Green Mountain Care) covers generic lisinopril, but a prior authorization (PA) step is required. This means your prescriber must submit clinical documentation before the plan will reimburse the drug. PA requirements for lisinopril in Vermont typically ask the provider to confirm the diagnosis (hypertension, heart failure, diabetic nephropathy, or post-myocardial infarction left ventricular dysfunction) and to note any contraindications to preferred-tier alternatives, if applicable.

Once approved, beneficiaries pay little to nothing out of pocket. Vermont's Medicaid program operates under federal best-price rules, which cap the amount a manufacturer may charge state Medicaid programs, bringing the effective ingredient cost to the state very low. The Vermont Agency of Human Services aligns its preferred drug list with evidence-based guidelines that consistently rate ACE inhibitors as first-line agents for hypertension in patients with diabetes or chronic kidney disease (CKD) [3].

The American Heart Association's 2023 hypertension guidelines state: "ACE inhibitors or ARBs are the preferred agents for patients with hypertension and CKD, with or without diabetes, due to their renal-protective effects." [4] That clinical consensus makes PA approval relatively straightforward for most patients who meet diagnostic criteria.

If your PA is denied, your prescriber can file an appeal or request a formulary exception. Vermont law requires Medicaid to respond to standard PA requests within 72 hours and to urgent requests within 24 hours.

Private Insurance and Lisinopril in Vermont

Most private insurance plans sold through Vermont Health Connect (the state's ACA marketplace) place generic lisinopril on Tier 1 of their formulary, the lowest-cost tier. Tier 1 copays across Vermont's major carriers generally run $0 to $15 per 30-day fill. Anthem, MVP Health Care, and Blue Cross Blue Shield of Vermont are the primary individual market insurers in the state, and all three have historically placed generic lisinopril on preferred generic tiers.

Employer-sponsored plans follow similar patterns. A 2023 IQVIA analysis found that generic ACE inhibitors carried an average patient cost-share of $3.47 per fill across commercial plans nationally, a figure that applies broadly to Vermont employer plans as well [5].

Medicare Part D enrollees in Vermont pay according to their specific plan's formulary. Most Part D plans place generic lisinopril on Tier 1 with a copay of $0 to $10. During the Medicare coverage gap ("donut hole"), generic drugs are subject to a 25% cost-sharing requirement under current law, though lisinopril's low list price keeps that amount modest. The $2,000 annual out-of-pocket cap introduced by the Inflation Reduction Act took effect for Part D enrollees in 2025, providing an additional floor of protection.

Is Compounded Lisinopril Legal in Vermont?

Compounded lisinopril is legal in Vermont when prepared by a 503A pharmacy operating under state board of pharmacy licensure. 503A pharmacies compound drugs for individual patients based on a valid prescription from a licensed prescriber. They are not permitted to produce large batches for general sale, but they can prepare patient-specific formulations including alternative strengths, liquid suspensions for patients who cannot swallow tablets, or combination formulations not commercially available.

The FDA's framework for 503A pharmacies under the Drug Quality and Security Act (DQSA) applies nationally, including Vermont [6]. Vermont's Board of Pharmacy enforces these rules at the state level. A compounded lisinopril preparation from a licensed 503A pharmacy in Vermont is legally dispensed and clinically appropriate when a patient has a demonstrated need for the compounded form.

Cost is where compounding sometimes becomes attractive beyond clinical necessity. Some 503A pharmacies, particularly those affiliated with telehealth platforms or employer wellness programs, offer compounded lisinopril at $0 per month to qualifying patients, effectively subsidizing the ingredient cost through program fees or manufacturer rebates on other products in their formulary. That price point is notable given the already-low cash price for branded generic tablets.

One important caveat: the FDA does not evaluate compounded drugs for safety or efficacy the way it evaluates approved drug products. Compounded lisinopril should carry the same active moiety as the approved product, but bioequivalence testing is not required. For a patient whose blood pressure is well-controlled on a commercial generic, switching to a compounded version introduces a variable that most clinicians would consider unnecessary [7].

Telehealth Prescribing of Lisinopril in Vermont

Vermont permits telehealth prescribing of lisinopril. Lisinopril is not a controlled substance, so the restrictions that apply to scheduled drugs under the Ryan Haight Act do not apply here. A Vermont-licensed prescriber can evaluate a patient via synchronous video visit, review a blood pressure reading the patient provides (ideally from a calibrated home monitor), and issue a prescription electronically to any Vermont-licensed pharmacy.

The Vermont Medical Practice Act and the state's telehealth statute do require that a valid patient-provider relationship be established before prescribing. For most telehealth platforms this means a documented clinical encounter, a review of relevant history and medications, and a care plan. A visit that consists only of a patient requesting a refill without clinical assessment does not satisfy that standard.

Home blood pressure monitoring is central to telehealth management of hypertension. The American Heart Association recommends using an upper-arm cuff device validated by the Association for the Advancement of Medical Instrumentation (AAMI) and taking two readings in the morning and two in the evening for seven days before a telehealth visit, then averaging the results [4]. A mean of 130/80 mmHg or higher on home monitoring supports initiating or adjusting therapy under the 2017 ACC/AHA hypertension guidelines.

Telehealth visits for lisinopril initiation or refill through platforms like HealthRX typically cost $50 to $75 per visit without insurance. With insurance, the visit copay is often $20 to $40. Vermont's commercial insurers are required by state law to reimburse telehealth services at the same rate as in-person services for covered benefits, which means a telehealth hypertension visit should generate the same reimbursement as an equivalent office visit.

How Lisinopril Works and Why Dose Matters for Cost

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor. It blocks the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. Blood pressure falls, cardiac afterload decreases, and in patients with CKD, glomerular capillary pressure is reduced, slowing progression of proteinuria.

FDA-approved indications include hypertension, heart failure (as adjunct therapy), and treatment of stable patients within 24 hours of acute myocardial infarction to improve survival [6]. Off-label use for diabetic nephropathy is supported by the REIN (Ramipril Efficacy in Nephropathy) trial family and by 2022 ADA Standards of Care, which recommend ACE inhibitors or ARBs for patients with diabetes and either hypertension or albuminuria [8].

Dose directly affects cost per milligram but not always cost per prescription. A 10 mg tablet and a 40 mg tablet of generic lisinopril often cost the same retail amount, because pharmacies price the fill, not the strength. A patient who needs 40 mg daily may not pay any more than a patient on 10 mg. Confirm this with your specific pharmacy.

Starting doses in treatment-naive hypertension are typically 5 to 10 mg once daily. The maximum approved dose for hypertension is 40 mg/day. Heart failure dosing usually starts at 2.5 to 5 mg/day and titrates to 40 mg/day as tolerated, per the ACC/AHA Heart Failure guidelines [9].

Key Safety Considerations That Affect Prescribing and Access

Lisinopril carries a black-box warning for fetal toxicity. It is contraindicated in pregnancy (all trimesters) and must not be prescribed to patients who are pregnant or planning pregnancy without a confirmed plan to switch or discontinue [6]. Vermont clinicians prescribing via telehealth should document pregnancy status and contraceptive use for patients of childbearing potential.

ACE inhibitor-induced cough occurs in roughly 10 to 15% of patients and is more common in patients of East Asian descent, with some studies citing rates above 30% in that population [10]. This is the most frequent reason for switching to an angiotensin receptor blocker (ARB) such as losartan. Angioedema is rare (0.1 to 0.7%) but potentially life-threatening and is an absolute contraindication to rechallenge with any ACE inhibitor.

Hyperkalemia is a concern in patients with CKD stage 3b or higher, in patients taking potassium-sparing diuretics, or in those on a high-potassium diet. Baseline and periodic monitoring of serum potassium and creatinine is standard of care. The 2012 KDIGO CKD guidelines and subsequent updates recommend checking potassium and creatinine at 1 to 4 weeks after initiating or dose-escalating an ACE inhibitor in CKD patients [11].

Renal artery stenosis (bilateral or in a solitary kidney) is a contraindication. Lisinopril may precipitate acute kidney injury in this setting by reducing efferent arteriolar tone and dropping glomerular filtration pressure below the threshold required for adequate filtration.

The Most Cost-Effective Path to Lisinopril in Vermont: A Decision Framework

Getting the lowest price depends on three variables: insurance status, pharmacy choice, and whether you need a compounded formulation.

If you have Vermont Medicaid: Apply for PA through your prescriber. Once approved, your cost is $0 or near-zero. Telehealth visits may count toward your covered benefits, reducing the cost of establishing care.

If you have commercial insurance (ACA marketplace or employer plan): Verify tier placement on your plan's formulary before filling. Most plans tier generic lisinopril at Tier 1 with a $0 to $15 copay. If your plan places brand-name Zestril on a higher tier, confirm with the pharmacist that you are receiving the generic.

If you are uninsured or underinsured: The cash price of roughly $8/month is already low. Applying a GoodRx or RxSaver coupon at checkout at Hannaford Pharmacy, Kinney Drugs, CVS, or Rite Aid in Vermont brings the price to the $4 to $9 range. Purchasing a 90-day supply instead of 30 days almost always reduces per-tablet cost. Vermont's Dr. Dynasaur and Medicaid expansion programs cover adults up to 138% of the federal poverty level. Patients above that threshold but still cost-sensitive may qualify for patient assistance programs through the originating manufacturers, though generic manufacturers rarely offer formal PAPs.

If you need a non-standard formulation: A 503A compounding pharmacy can prepare a liquid suspension for patients who cannot swallow tablets, or an alternative strength not commercially available. Some telehealth-affiliated compounding pharmacies offer this at $0 per month within their subscription models. Confirm the pharmacy's 503A licensure with the Vermont Board of Pharmacy before filling a compounded prescription.

Vermont-Specific Resources for Prescription Assistance

Vermont has several state-level programs that interact with drug costs. VPharm is a state pharmaceutical assistance program for Vermont seniors and people with disabilities who do not qualify for full Medicaid but face high drug costs. VPharm provides a subsidy on prescription copays for eligible residents. Details are available through the Vermont Department of Vermont Health Access.

The 340B Drug Pricing Program applies to qualifying federally qualified health centers (FQHCs) and rural health clinics in Vermont, including several in Burlington, Rutland, St. Johnsbury, and Barre. Patients who receive care at these facilities may access lisinopril at 340B pricing, which is substantially below standard retail. The Health Resources and Services Administration (HRSA) maintains a public database of Vermont 340B-covered entities [12].

Prescription drug monitoring in Vermont falls under Act 173 (2016), which established the Vermont Prescription Monitoring System (VPMS). ACE inhibitors are not scheduled substances and are not subject to VPMS reporting requirements, simplifying prescribing logistics for telehealth providers and pharmacies alike.

What to Tell Your Prescriber Before Starting Lisinopril

A productive initial visit, whether in-person or via telehealth, should cover the following: current blood pressure readings (at least two readings on two separate days), kidney function (serum creatinine or eGFR if available), potassium level, any history of angioedema with any drug, current medications including NSAIDs and potassium supplements, and pregnancy status.

NSAIDs (ibuprofen, naproxen) blunt the antihypertensive effect of lisinopril and may accelerate renal function decline when combined with ACE inhibitors and a low-sodium state. This interaction is clinically significant in elderly patients and in anyone with CKD [13].

Dual ACE inhibitor and ARB therapy is not recommended. The ONTARGET trial (N=25,620) showed that combining ramipril and telmisartan did not reduce cardiovascular outcomes compared to monotherapy and increased rates of hypotension, syncope, and renal impairment [14]. The same principle applies to combining lisinopril with any ARB.

A baseline blood pressure reading below 130/80 mmHg on home monitoring, taken correctly and averaged over seven days, represents the 2017 ACC/AHA target for most adults under 65 [4]. Achieving that target on lisinopril monotherapy is possible for patients with stage 1 hypertension (130 to 139/80 to 89 mmHg). Patients with stage 2 hypertension (140/90 mmHg or higher) often require two agents, and lisinopril is frequently combined with a thiazide diuretic (hydrochlorothiazide or chlorthalidone) or a dihydropyridine calcium channel blocker (amlodipine) for additive effect.